BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23780894)

  • 1. Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population.
    Wu D; Jiang H; Gu Q; Zhang D; Li Z
    Tumour Biol; 2013 Oct; 34(5):3265-9. PubMed ID: 23780894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis.
    Wei X; Chen D; Lv T
    Mol Biol Rep; 2013 Jan; 40(1):567-72. PubMed ID: 23096083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis.
    Qi Y; Cui L; Song Y; Li N
    Mol Biol Rep; 2014 Feb; 41(2):879-87. PubMed ID: 24390232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XRCC1 Arg399Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.
    Liu B; Shen T
    Tumour Biol; 2014 Jan; 35(1):507-12. PubMed ID: 24052436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
    Xie T; Wang ZG; Zhang JL; Liu H
    World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between X-ray repair cross-complementation group 1 rs25487 polymorphism and pancreatic cancer risk.
    Jiang H; Wu D; Ma D; Lin G; Liang J; Jin J
    Tumour Biol; 2013 Dec; 34(6):3417-21. PubMed ID: 23807675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis.
    Zeng FR; Ling Y; Yang J; Tian XC; Yang X; Luo RC
    Tumour Biol; 2013 Feb; 34(1):555-63. PubMed ID: 23188703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis.
    Li J; Li Z; Feng L; Guo W; Zhang S
    Tumour Biol; 2013 Feb; 34(1):261-9. PubMed ID: 23055199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the XRCC1 Arg399Gln polymorphism and risk of cervical carcinoma: a meta-analysis.
    Liu DY; Liang HC; Xiao XM
    Genet Mol Res; 2015 Aug; 14(3):9821-8. PubMed ID: 26345915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the association between XRCC1 Arg399Gln polymorphism and lung cancer in Chinese.
    Li Y; Huang Y; Cao YS; Zeng J; Tong WN; Xu SL; Zhuo AS
    Tumour Biol; 2013 Dec; 34(6):3681-5. PubMed ID: 23884604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An updated meta-analysis between the association of XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk.
    Zhang XL; Lu Y; Yang S; Peng QL; Wang J; Xie L; Deng Y; He Y; Li TJ; Qin X; Li S
    Asian Pac J Cancer Prev; 2014; 15(7):3273-8. PubMed ID: 24815482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population.
    Tian Z; Li YL; Liu JG
    Mol Biol Rep; 2013 Jul; 40(7):4147-51. PubMed ID: 23712778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An updated meta-analysis on the association of X-ray repair cross complementing group 1 codon 399 polymorphism with hepatocellular carcinoma risk.
    Wang YD; Zhai WL; Wang HY; Xia XQ
    Asian Pac J Cancer Prev; 2014; 15(11):4443-8. PubMed ID: 24969866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
    Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
    Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The XRCC1 Arg399Gln genetic polymorphism contributes to hepatocellular carcinoma susceptibility: an updated meta-analysis.
    Pan Y; Zhao L; Chen XM; Gu Y; Shen JG; Liu LM
    Asian Pac J Cancer Prev; 2013; 14(10):5761-7. PubMed ID: 24289575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Chinese Han population: a meta-analysis.
    Duan WH; Zhu ZY; Liu JG; Dong MS; Chen JZ; Liu QD; Xie Y; Sun TY; Gao ZF; Zhou NX
    Asian Pac J Cancer Prev; 2012; 13(8):3601-4. PubMed ID: 23098440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between X-ray repair cross-complementing group 1 Arg194Trp polymorphism and colorectal cancer risk.
    Mao D; Zhang Y; Lu H; Fu X
    Tumour Biol; 2013 Oct; 34(5):2529-38. PubMed ID: 23857281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between XRCC1 gene polymorphisms and risk of glioma development: a meta-analysis.
    Sun JY; Zhang CY; Zhang ZJ; Dong YF; Zhang AL; Wang ZW; Mei XL
    Asian Pac J Cancer Prev; 2012; 13(9):4783-8. PubMed ID: 23167420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of RAD51 G135C and XRCC1 Arg399Gln polymorphisms on ovarian carcinoma risk in Serbian women.
    Malisic EJ; Krivokuca AM; Boljevic IZ; Jankovic RN
    Cancer Biomark; 2015; 15(5):685-91. PubMed ID: 26406958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XRCC1 Arg399Gln gene polymorphism and breast cancer risk: a meta-analysis based on case-control studies.
    Wu K; Su D; Lin K; Luo J; Au WW
    Asian Pac J Cancer Prev; 2011; 12(9):2237-43. PubMed ID: 22296363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.